Ogilvy brings Sandoz to Germany
The Basel-based pharmaceutical company Novartis plans to consolidate its generic drug business under the name Sandoz. Ogilvy Healthcare has won the account for the brand's relaunch in Germany.
The Basel-based chemical group Novartis intends to bundle its generics business under the name Sandoz in future. According to press reports, Ogilvy Healthcare won the account for the relaunch of the brand in Germany against Euro RSCG Life and Publicis Vital. A campaign focusing on specialist advertising will be launched at the beginning of 2004. Sandoz replaces the Azupharma brand in Germany; in Switzerland, Schönenberger Pharma is part of the new Sandoz.
